PROJECT STAGE
Lead optimisation
Hit to lead
Screening
Assay Development
Key
  • Small molecule
  • Biotherapeutics
  • Antibody drug conjugate
ULK1/2
Cancer
Confidential TB target
Anti-microbial
MIF
Inflammation
Matriptase
Inflammation
IL-16
Inflammation
TAPAS
Alzheimer’s Disease
GalR2
Neuropathic Pain
Netrin-1
Cardiovascular disease; osteolytic diseases /oncology